Valuation: Avinger, Inc.

Market Cap 27.07L 23.45L 22.17L 20.07L 37.68L 26Cr 37.96L 2.65Cr 1.02Cr 13Cr 1.02Cr 99.43L 42Cr P/E 2022
-0.25x
P/E 2023 -0.19x
Enterprise Value 1.28Cr 1.11Cr 1.05Cr 95.12L 1.79Cr 123.04Cr 1.8Cr 13Cr 4.82Cr 62Cr 4.82Cr 4.71Cr 198.97Cr EV / Sales 2022
1.19x
EV / Sales 2023 1.78x
Free-Float
88.44%
Yield 2022 *
-
Yield 2023 -
3 years 0.36
Extreme 0.363
14
5 years 0.36
Extreme 0.363
288.9
10 years 0.36
Extreme 0.363
6,18,002.47
Manager TitleAgeSince
Chief Executive Officer - -
Chief Tech/Sci/R&D Officer - 05/08/2024
Date Insider Type Main position Quantity % Market Cap. Importance
23/01/25 Sell

Founder

2,215 0.0669%
23/01/25 Sell

Chief Financial Officer

1,255 0.0379%
23/01/25 Sell

Chief Executive Officer

3,690 0.1115%
Change 5-day change 1-year change 3-year change Capi.($)
-20.74%-.--%-.--%-88.54% 15.15L
-0.33%-4.66%-32.89%-4.04% 1.24TCr
+1.66%-2.24%+14.29%+7.71% 418.23Cr
-1.95%-11.95%-47.88%-61.39% 117.32Cr
-0.88%-5.86%-45.86%-45.15% 105.38Cr
-0.15%-2.36%+15.08%+76.43% 105.38Cr
-0.20%-6.09%-40.05% - 96Cr
-0.03%-6.55% - - 96Cr
-0.57%-5.37%+31.06%+98.04% 50Cr
-2.00%+0.31%+47.34% - 32Cr
Average -2.52%+0.18%-6.54%-2.42% 226.3Cr
Weighted average by Cap. -0.08%-1.91%-20.55%-0.39%

Financials

2022 2023
Net sales 82.73L 71.66L 67.76L 61.35L 1.15Cr 79Cr 1.16Cr 8.09Cr 3.11Cr 40Cr 3.11Cr 3.04Cr 128.33Cr 76.52L 66.28L 62.68L 56.74L 1.06Cr 73Cr 1.07Cr 7.48Cr 2.88Cr 37Cr 2.87Cr 2.81Cr 118.7Cr
Net income -1.76Cr -1.53Cr -1.44Cr -1.31Cr -2.45Cr -169.05Cr -2.47Cr -17Cr -6.63Cr -86Cr -6.62Cr -6.47Cr -273.36Cr -1.83Cr -1.59Cr -1.5Cr -1.36Cr -2.55Cr -175.73Cr -2.57Cr -18Cr -6.89Cr -89Cr -6.88Cr -6.73Cr -284.18Cr
Net Debt 17.56L 15.21L 14.38L 13.02L 24.44L 17Cr 24.62L 1.72Cr 66.03L 8.54Cr 65.96L 64.5L 27Cr 1.01Cr 87.66L 82.89L 75.04L 1.41Cr 97Cr 1.42Cr 9.89Cr 3.81Cr 49Cr 3.8Cr 3.72Cr 156.98Cr
Logo Avinger, Inc.
Avinger Inc is a United States-based company. The Company operates as a medical device company that designs, manufactures, and sells image-guided, catheter-based systems for treating peripheral artery disease (PAD). Its products are used by interventional cardiologists, vascular surgeons, and interventional radiologists in the United States and select international markets and are based on its Lumivascular platform, a system that uses optical coherence tomography (OCT) for real-time visualization inside arteries. Its products includes the Lightbox imaging console, Ocelot and Tigereye catheters for crossing blockages, and Pantheris for removing plaque.
Employees
70
  1. Stock Market
  2. Stocks
  3. AVGR Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!